z-logo
open-access-imgOpen Access
Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma
Author(s) -
Alfred L. Garfall,
Edward A. Stadtmauer,
WeiTing Hwang,
Simon F. Lacey,
J. Joseph Melenhorst,
Maria Krevvata,
Martin Carroll,
William Matsui,
Qiuju Wang,
Madhav V. Dhodapkar,
Kavita M. Dhodapkar,
Rituparna Das,
Dan T. Vogl,
Brendan M. Weiss,
Adam D. Cohen,
Patricia Mangan,
Emily C. Ayers,
Selene Nuñez-Cruz,
Irina Kulikovskaya,
Megan M. Davis,
Anne Lamontagne,
Karen Dengel,
Naseem Kerr,
Regina M. Young,
Donald L. Siegel,
Bruce L. Levine,
Michael C. Milone,
Marcela V. Maus,
Carl H. June
Publication year - 2019
Publication title -
jci insight
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.099
H-Index - 45
ISSN - 2379-3708
DOI - 10.1172/jci.insight.127684
Subject(s) - melphalan , multiple myeloma , transplantation , stem cell , autologous stem cell transplantation , refractory (planetary science) , medicine , cancer research , cd19 , oncology , biology , peripheral blood , microbiology and biotechnology , astrobiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here